Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Physical Therapy Modalities × Breast × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Genitourinary 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1 CNS 1 Breast 1

Conditions

Motor Activity 1 Breast Neoplasms 1

Interventions

Paclitaxel 142 Fulvestrant 138 Trastuzumab 136 pembrolizumab 125 Letrozole 120 Carboplatin 104 Capecitabine 92 Specimen Handling 88 Cyclophosphamide 88 pertuzumab 84 Anastrozole 78 Docetaxel 77 Magnetic Resonance Spectroscopy 76 abemaciclib 73 palbociclib 66 Tamoxifen 65 exemestane 63 ribociclib 61 trastuzumab deruxtecan 60 Radiotherapy 59 Biopsy 52 olaparib 50 Surveys and Questionnaires 48 sacituzumab govitecan 46 130-nm albumin-bound paclitaxel 46 Gemcitabine 43 Doxorubicin 43 Blood Specimen Collection 43 eribulin 41 Standard of Care 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05254678 2026-02-05

Empower

University of Alberta

Phase NA Completed

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡